Biblio

Export 1713 results:
Author [ Title(Asc)] Type Year
Filters: First Letter Of Last Name is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
I. Cuchillo-Ibañez, Balmaceda, V., Mata-Balaguer, T., Lopez-Font, I., and Sáez-Valero, J., “Reelin in Alzheimer's Disease, Increased Levels but Impaired Signaling: When More is Less.”, J Alzheimers Dis, vol. 52, no. 2, pp. 403-16, 2016.
L. D. Estrada, Chamorro, D., Yañez, M. José, Gonzalez, M., Leal, N., von Bernhardi, R., Dulcey, A. E., Marugan, J., Ferrer, M., Soto, C., Zanlungo, S., Inestrosa, N. C., and Alvarez, A. R., “Reduction of Blood Amyloid-β Oligomers in Alzheimer's Disease Transgenic Mice by c-Abl Kinase Inhibition.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1193-1205, 2016.
S. Tholen, Schmaderer, C., Chmielewski, S., Förstl, H., Heemann, U., Baumann, M., Steubl, D., and Grimmer, T., “Reduction of Amyloid-β Plasma Levels by Hemodialysis: An Anti-Amyloid Treatment Strategy?”, J Alzheimers Dis, vol. 50, no. 3, pp. 791-6, 2016.
W. - S. Jin, Le Bu, X. -, Wang, Y. - R., Li, L., Li, W. - W., Liu, Y. - H., Zhu, C., Yao, X. - Q., Chen, Y., Gao, C. - Y., Zhang, T., Gao, C. - Y., Zhou, H. - D., Zeng, F., and Wang, Y. - J., “Reduced Cardiovascular Functions in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 3, pp. 919-925, 2017.
D. A. Loewenstein, Curiel, R. E., Wright, C., Sun, X., Alperin, N., Crocco, E., Czaja, S. J., Raffo, A., Penate, A., Melo, J., Capp, K., Gamez, M., and Duara, R., “Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1119-1126, 2017.
D. A. Loewenstein, Curiel, R. E., Wright, C., Sun, X., Alperin, N., Crocco, E., Czaja, S. J., Raffo, A., Penate, A., Melo, J., Capp, K., Gamez, M., and Duara, R., “Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1119-1126, 2017.
D. A. Loewenstein, Curiel, R. E., Wright, C., Sun, X., Alperin, N., Crocco, E., Czaja, S. J., Raffo, A., Penate, A., Melo, J., Capp, K., Gamez, M., and Duara, R., “Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1119-1126, 2017.
D. A. Loewenstein, Curiel, R. E., Wright, C., Sun, X., Alperin, N., Crocco, E., Czaja, S. J., Raffo, A., Penate, A., Melo, J., Capp, K., Gamez, M., and Duara, R., “Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1119-1126, 2017.
D. A. Loewenstein, Curiel, R. E., DeKosky, S., Rosselli, M., Bauer, R., Grieg-Custo, M., Penate, A., Li, C., Lizagarra, G., Golde, T., Adjouadi, M., and Duara, R., “Recovery from Proactive Semantic Interference and MRI Volume: A Replication and Extension Study.”, J Alzheimers Dis, vol. 59, no. 1, pp. 131-139, 2017.
M. Pacheco Pachado, Casas, A. I., Elbatreek, M. H., Nogales, C., Guney, E., Espay, A. J., and Schmidt, H. H. H. W., “Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes.”, J Alzheimers Dis, vol. 96, no. 1, pp. 47-56, 2023.
J. Gu, Chen, F., Chu, D., Lu, Y., Iqbal, K., Gong, C. - X., and Liu, F., “Rbfox3/NeuN Regulates Alternative Splicing of Tau Exon 10.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1695-1704, 2018.
J. Gu, Chen, F., Chu, D., Lu, Y., Iqbal, K., Gong, C. - X., and Liu, F., “Rbfox3/NeuN Regulates Alternative Splicing of Tau Exon 10.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1695-1704, 2018.
P. G. Kehoe, Blair, P. S., Howden, B., Thomas, D. L., Malone, I. B., Horwood, J., Clement, C., Selman, L. E., Baber, H., Lane, A., Coulthard, E., Passmore, A. Peter, Fox, N. C., Wilkinson, I. B., and Ben-Shlomo, Y., “The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial.”, J Alzheimers Dis, vol. 61, no. 2, pp. 803-814, 2018.
P. G. Kehoe, Blair, P. S., Howden, B., Thomas, D. L., Malone, I. B., Horwood, J., Clement, C., Selman, L. E., Baber, H., Lane, A., Coulthard, E., Passmore, A. Peter, Fox, N. C., Wilkinson, I. B., and Ben-Shlomo, Y., “The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial.”, J Alzheimers Dis, vol. 61, no. 2, pp. 803-814, 2018.
W. Wharton, Goldstein, F. C., Tansey, M. G., Brown, A. L., Tharwani, S. D., Verble, D. D., Cintron, A., and Kehoe, P. G., “Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.”, J Alzheimers Dis, vol. 61, no. 2, pp. 815-824, 2018.
M. - S. Tan, Zhu, J. - X., Cao, X. - P., Yu, J. - T., and Tan, L., “Rare Variants in PLD3 Increase Risk for Alzheimer's Disease in Han Chinese.”, J Alzheimers Dis, vol. 64, no. 1, pp. 55-59, 2018.
E. Louwersheimer, Cohn-Hokke, P. E., Pijnenburg, Y. A. L., Weiss, M. M., Sistermans, E. A., Rozemuller, A. J., Hulsman, M., van Swieten, J. C., van Duijn, C. M., Barkhof, F., Koene, T., Scheltens, P., van der Flier, W. M., and Holstege, H., “Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity.”, J Alzheimers Dis, vol. 56, no. 1, pp. 63-74, 2017.
L. Sun, Chen, K., Li, X., and Xiao, S., “Rapidly Progressive Frontotemporal Dementia Associated with MAPT Mutation G389R.”, J Alzheimers Dis, vol. 55, no. 2, pp. 777-785, 2017.
S. Abu-Rumeileh, Capellari, S., and Parchi, P., “Rapidly Progressive Alzheimer's Disease: Contributions to Clinical-Pathological Definition and Diagnosis.”, J Alzheimers Dis, 2018.
M. R. Farlow, Thompson, R. E., Wei, L. - J., Tuchman, A. J., Grenier, E., Crockford, D., Wilke, S., Benison, J., and Alkon, D. L., “A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease.”, J Alzheimers Dis, vol. 67, no. 2, pp. 555-570, 2019.
C. Dallaire-Théroux, Callahan, B. L., Potvin, O., Saikali, S., and Duchesne, S., “Radiological-Pathological Correlation in Alzheimer's Disease: Systematic Review of Antemortem Magnetic Resonance Imaging Findings.”, J Alzheimers Dis, vol. 57, no. 2, pp. 575-601, 2017.
C. W. Zhu, Gu, Y., Cosentino, S., Kociolek, A. J., Hernandez, M., and Stern, Y., “Racial/Ethnic Disparities in Misidentification of Dementia in Medicare Claims: Results from the Washington Heights-Inwood Columbia Aging Project.”, J Alzheimers Dis, vol. 96, no. 1, pp. 359-368, 2023.
C. B. Wright, DeRosa, J. T., Moon, M. P., Strobino, K., DeCarli, C., Cheung, Y. Kuen, Assuras, S., Levin, B., Stern, Y., Sun, X., Rundek, T., Elkind, M. S. V., and Sacco, R. L., “Race/Ethnic Disparities in Mild Cognitive Impairment and Dementia: The Northern Manhattan Study.”, J Alzheimers Dis, vol. 80, no. 3, pp. 1129-1138, 2021.
T. Yan, Wang, L., Gao, J., Siedlak, S. L., Huntley, M. L., Termsarasab, P., Perry, G., Chen, S. G., and Wang, X., “Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 1, pp. 157-165, 2018.
Q
J. C. Triplett, Swomley, A. M., Cai, J., Klein, J. B., and D Butterfield, A., “Quantitative phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 45-62, 2016.

Pages